Author's response to: letter to the editor
Heart Fail Rev
.
2018 Sep;23(5):819.
doi: 10.1007/s10741-018-9728-6.
Authors
Anne Pernille Ofstad
1
2
,
Dan Atar
3
4
,
Lars Gullestad
4
5
,
Gisle Langslet
6
,
Odd Erik Johansen
7
8
Affiliations
1
Bærum Hospital, Vestre Viken HF, Rud, Norway. Annepernille@hotmail.com.
2
Medical department, Boehringer Ingelheim, Asker, Norway. Annepernille@hotmail.com.
3
Department of Cardiology B, Oslo University Hospital, Ullevål hospital, Oslo, Norway.
4
Faculty of Medicine, University of Oslo, Oslo, Norway.
5
Department of cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
6
Lipid clinic, Oslo University Hospital, Rikshospitalet, Oslo, Norway.
7
Bærum Hospital, Vestre Viken HF, Rud, Norway.
8
Medical department, Boehringer Ingelheim, Asker, Norway.
PMID:
30043131
DOI:
10.1007/s10741-018-9728-6
No abstract available
Publication types
Letter
Comment
MeSH terms
Diabetes Mellitus, Type 2*
Heart Failure*
Humans